Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

News Daily News

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

Caitlin E. Cox

November 15, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

Presentation TCT 2023

TCT 646: Percutaneous Tricuspid Valve-in-Valve Implantation in Failed Surgical Bioprosthetic Valves - Brazilian Single Center Registry

Presenter: Filippe Filippini

October 25, 2023

Presentation TCT 2023

TCT 350: Statistics of In-patient Mortality and Associated Variables of Transcatheter Mitral Valve-in-Valve (TMVR ViV) Procedure in Mitral Stenosis and Mitral Regurgitation with Bioprosthetic Valve- A Nationwide Analysis

Presenter: Aneeza Jamshed

October 25, 2023

Presentation TCT 2023

Position 2: Initial SAVR With Bioprosthetic Valve/Ross

Presenter: S. Chris Malaisrie

October 25, 2023

Presentation TCT 2023

TCT 710: Valve-in-Valve Transcatheter Aortic Valve Replacement in Failed Trifecta Bioprosthetic Aortic Valve

Presenter: Shivabalan Kathavarayan Ramu

October 25, 2023

Presentation TCT 2023

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

Presenter: Michael Reardon

October 25, 2023

Presentation TCT 2023

TCT 520: Impact of Ballon Dilatation in ViV-TAVR according to Bioprosthetic Aortic Valve Type.

Presenter: Athanasios Koutsoukis

October 25, 2023

Presentation TCT 2023

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

Presenter: Francesco Giannini

October 25, 2023

Presentation TCT 2023

TCT 772: Transcatheter Electrosurgical Leaflet Splitting to Prevent TAVR-induced Coronary Obstruction in Stented vs. Stentless Bioprosthetic Aortic Valves: Results From the Multicenter EURO-BASILICA Registry

Presenter: Ines Richter

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2023

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

Presenter: Yousef Darestani

October 24, 2023

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News EuroPCR 2023

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Caitlin E. Cox

May 19, 2023

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

News Conference News EuroPCR 2023

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Michael O'Riordan

May 16, 2023

News Conference News AATS 2023

Beware High-Risk TAVI in Patients With Low-Lying Coronaries

Michael O'Riordan

May 11, 2023

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

News Daily News

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

Todd Neale

February 27, 2023

Advertisement

Ross Procedure Offers ‘Excellent Survival’ 25 Years Out

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

TCT 646: Percutaneous Tricuspid Valve-in-Valve Implantation in Failed Surgical Bioprosthetic Valves - Brazilian Single Center Registry

TCT 350: Statistics of In-patient Mortality and Associated Variables of Transcatheter Mitral Valve-in-Valve (TMVR ViV) Procedure in Mitral Stenosis and Mitral Regurgitation with Bioprosthetic Valve- A Nationwide Analysis

Position 2: Initial SAVR With Bioprosthetic Valve/Ross

TCT 710: Valve-in-Valve Transcatheter Aortic Valve Replacement in Failed Trifecta Bioprosthetic Aortic Valve

Current Knowledge of Durability of Bioprosthetic Valves (SAVR and TAVR)

TCT 520: Impact of Ballon Dilatation in ViV-TAVR according to Bioprosthetic Aortic Valve Type.

TCT 519: Coronary access and percutaneous coronary intervention feasibility after transcatheter aortic valve replacement in failed bioprosthetic valves with ACURATE neo2 versus Evolut PRO+

TCT 772: Transcatheter Electrosurgical Leaflet Splitting to Prevent TAVR-induced Coronary Obstruction in Stented vs. Stentless Bioprosthetic Aortic Valves: Results From the Multicenter EURO-BASILICA Registry

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

MITRAL at 5 Years: TMVR for MAC, Failing Devices Shows Ongoing Impact

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

BASILICA, Chimney Stenting: No Clear Winner to Prevent TAVI Coronary Obstruction

Beware High-Risk TAVI in Patients With Low-Lying Coronaries

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content